Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab vs Deferoxamine in COVID-19 ICU Patients
NCT04361032Phase 3Unknown
- Sponsor
- Abderrahmane Mami Hospital
- Start
- Sep 2020
- Primary completion
- Sep 2020
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in coronavirus disease 2019 (COVID-19), sponsored by Abderrahmane Mami Hospital. Status: unknown.
02
Drugs
tocilizumab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04361032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04361032.